Can I stop taking Ripotinib once I take it?

Repotrectinib is a new generation of multi-target tyrosine kinase inhibitor, mainly used to treat patients with ROS1-positive locally advanced or metastatic non-small cell lung cancer (NSCLC). Targeting this special target, repotinib has shown significant clinical efficacy, especially in drug-resistant patients. However, whether it cannot be stopped once taken requires a comprehensive judgment based on the patient's specific condition and treatment response.

Reputinib is a targeted therapy drug. Its mechanism of action is to inhibit the abnormal activation of ROS1 fusion protein in tumor cells, thereby blocking tumor growth signals and inhibiting tumor progression. Unlike chemotherapy, targeted drugs usually require long-term maintenance medication to continue to control tumor growth. Stopping medication often leads to the reactivation of tumor cells and the risk of disease progression or recurrence, so doctors usually recommend that patients continue to take medication according to the treatment plan.

However, the safety of long-term medication and patient tolerance are also key considerations. Some patients may need to adjust the dose or temporarily discontinue the drug due to side effects or physical conditions. With in-depth clinical monitoring, doctors will adjust the treatment strategy based on the patient's actual response, tumor burden, and quality of life. Therefore, there is no absolute "cannot stop" of repotinib, but stopping the drug without the guidance of a doctor may lead to increased risk of disease recurrence and drug resistance, and patients are not recommended to stop the drug on their own. Regular follow-up and imaging evaluation are extremely important for judging efficacy and adjusting medication.

In short, as a targeted therapy drug, repotinib usually needs to be taken continuously for a long time to maintain its efficacy. The decision to discontinue the drug must be made under the guidance of a professional medical team to ensure that patients get the best therapeutic effect and safety.

Reference materials:https://www.drugs.com/mtm/repotrectinib.html